Home/Filings/4/0001181431-10-004166
4//SEC Filing

Schmidt Keith 4

Accession 0001181431-10-004166

CIK 0001333763other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 8:50 PM ET

Size

9.6 KB

Accession

0001181431-10-004166

Insider Transaction Report

Form 4
Period: 2010-01-19
Schmidt Keith
Vice Pres. Marketing and Sales
Transactions
  • Award

    Stock Option (Right to Buy)

    2010-01-19+50,00050,000 total
    Exercise: $2.96Exp: 2020-01-19Common Stock (50,000 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $5.45Exp: 2017-01-31Common Stock (75,000 underlying)
    75,000
  • Stock Option (Right to Buy)

    Exercise: $1.78Exp: 2019-01-22Common Stock (50,000 underlying)
    50,000
  • Stock Option (Right to Buy)

    Exercise: $6.50Exp: 2018-01-24Common Stock (50,000 underlying)
    50,000
Footnotes (4)
  • [F1]Option vests in four equal annual installments beginning on January 19, 2011.
  • [F2]Option vests in four equal annual installments beginning on January 22, 2010.
  • [F3]Option vests in four equal annual installments beginning on January 24, 2009.
  • [F4]Option vests in four equal annual installments beginning on February 1, 2008.

Issuer

Chelsea Therapeutics International, Ltd.

CIK 0001333763

Entity typeother

Related Parties

1
  • filerCIK 0001389235

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 8:50 PM ET
Size
9.6 KB